ABSTRACT
Acanthamoeba spp. are free-living amoebae that are ubiquitously distributed in the environment and can cause encephalomyelitis in animals and humans. The factors that contribute to Acanthamoeba infections include parasite biology, genetic diversity, environmental spread, and host susceptibility. The aim of the present study was to characterize isolates of Acanthamoeba from the nasal mucosa and cutaneous lesions of dogs in order to access the occurence and pathogenicity of these organisms in this animal group. We studied 13 isolates of Acanthamoeba confirmed by polymerase chain reaction. They were sequenced, the genotype was determined, and their potential of pathogenicity was evaluated.
Subject(s)
Acanthamoeba/classification , Acanthamoeba/isolation & purification , Amebiasis/veterinary , Dog Diseases/parasitology , Nasal Mucosa/parasitology , Wounds and Injuries/parasitology , Acanthamoeba/genetics , Acanthamoeba/pathogenicity , Amebiasis/parasitology , Animals , DNA, Protozoan/chemistry , DNA, Protozoan/genetics , Dogs , Genotype , Molecular Sequence Data , Polymerase Chain Reaction , Sequence Analysis, DNA , VirulenceABSTRACT
OBJECTIVES: The first aim of this study was to evaluate the in vitro efficacies of fluconazole, ketoconazole, itraconazole and voriconazole on M. pachydermatis growth inhibition. This study also evaluated M. pachydermatis azole cross-resistance, comparing wild clinical isolates and the same isolates with in vitro-induced fluconazole resistance. METHODS: Two techniques were used: (1) a broth microdilution method based on protocol M27-A3 from the Clinical and Laboratory Standards Institute to determine the minimum inhibitory concentration (MIC) and (2) the Fekete-Forgács method to induce fluconazole resistance in vitro. The isolates were divided into two groups: group 1 included fluconazole-susceptible clinical isolates (n=30) and group 2 contained the same isolates with in vitro-induced fluconazole resistance (n=30). RESULTS: The two groups exhibited differences in susceptibility (p<0.001). Group 1 isolates were susceptible to azoles: ketoconazole (MIC 0.01-1.0 µg/mL), itraconazole (MIC 0.01-1.0 µg/mL), voriconazole (MIC 0.01-4.0 µg/mL), and fluconazole (MIC 0.01-4.0 µg/mL). Group 2 isolates demonstrated a wider range of MICs to azoles: ITZ (MIC 0.06-64.0 µg/mL), KTZ (MIC 0.25-32.0 µg/mL), VRZ (MIC 2.0-128.0 µg/mL), and FLZ (MIC 64.0-128.0 µg/mL). CONCLUSIONS: It was shown that FLZ-resistant M. pachydermatis isolates exhibit cross-resistance to other azoles, reinforcing the importance of susceptibility tests as a guide for the therapeutic prescription of antifungals in medical and veterinary mycology.
